NCT05318339 2022-04-08
A Study of Trastuzumab and Pyrotinib in HER2 Positive Locally Advanced or Metastatic Urothelial Carcinoma
ChineseAMS
Phase 2 Unknown
Clinical Trials
6 trialsNCT05020964 2021-08-25
Screening Plasma HER2 Amplication by Digital PCR in Advanced Breast Cancer Patients Treated With Trastuzumab and Pyrotinib
ChineseAMS
Phase 2 Unknown
NCT04033172 2019-07-25
Pyrotinib
ChineseAMS
Phase 2 Unknown
NCT03933982 2019-05-29
Pyrotinib
ChineseAMS
Phase 2 Unknown
NCT03923166 2019-04-22
Pyrotinib Combined With Capecitabine Metronomic Therapy in HER2-postitive Advanced Breast Cancer
ChineseAMS
Phase 2 Unknown
NCT03923179 2019-04-22
Phase II Clinical Study of Pyrotinib Combined With Etoposide to Treat HER2-positive Advanced Breast Cancer
ChineseAMS
Phase 2 Unknown